Pauline Kenny
General Counsel, Proteostasis Therapeutics (United States).
Companies
- Proteostasis Therapeutics (United States)General counsel Dec 20, 2022 to Sep 21, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Proteostasis Therapeutics (United States)18,448 shares2Sep 20, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 20, 2023Bought 1,500 shares at $2.58 of Proteostasis Therapeutics (United States)2
- Jun 14, 2023Shares withheld for tax 858 shares at $2.82 of Proteostasis Therapeutics (United States)3
- Mar 20, 2023Sold 544 shares at $3.29 of Proteostasis Therapeutics (United States)4
- Mar 17, 2023Sold 22 shares at $5.23 of Proteostasis Therapeutics (United States)4
- Mar 17, 2023Sold 745 shares at $4.94 of Proteostasis Therapeutics (United States)4
- Dec 16, 2022Granted 3,440 shares of Proteostasis Therapeutics (United States)5
- Dec 16, 2022Granted 5,042 shares of Proteostasis Therapeutics (United States)5
- Dec 16, 2022Granted 10,635 shares of Proteostasis Therapeutics (United States)5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jun 16, 2023
- 4SEC EDGARForm 4 filed Mar 21, 2023
- 5SEC EDGARForm 4 filed Dec 20, 2022